Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Urologi Sandfeldt AB
AB
Active
Org 5591632145
Medical specialists activities · NACE 8622
Est. 2018
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 0
EBITDA margin
—
+76% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -390
+91% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 0
—
EBITDA
SEK -1K
+76%
Net profit
SEK -390
+91%
Total assets
SEK 51K
-5%
Equity
SEK 51K
-1%
Employees
0
—
Company information
Legal name
Urologi Sandfeldt AB
Org number
5591632145
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
21 juni 2018
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Hälso- och sjukvård.
Contact
Address
Email
larssandfeldt@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Botkyrka
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
647
0
0
0
0
Staff expenses
—
−0
−0
−0
−0
EBITDA
64
−6
−11
−5
−1
Depreciation & amort.
−0
—
—
—
—
EBIT
64
−6
−11
−5
−1
Net financials
—
−0
0
1
1
Profit before tax
64
−7
−11
−5
−0
Tax
−14
—
—
—
—
Net profit
50
−7
−11
−5
−0
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
400
294
90
54
51
Equity
474
284
86
51
51
Long-term debt
0
—
—
—
—
Short-term debt
74
10
5
2
0
Total debt
74
10
5
2
—
Financial ratios
5-year trend
EBITDA margin
-133300.0%
This company
15.8%
Market median
-843771% vs market
2021
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2021
2025
Return on equity
-0.8%
This company
18.4%
Market median
-104% vs market
2021
2025
Net profit margin
-39000.0%
This company
8.1%
Market median
-481581% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BS
Bibbi Sandfeldt
Deputy Board Member
2022
LE
Lars Erik Sandfeldt
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Urologi Sandfeldt AB also hold positions in
0
other companies.
Person
Role here
Other companies
Bibbi Sandfeldt
Deputy Board Member
0 companies
Lars Erik Sandfeldt
Board of Directors
0 companies